Poly-Tussin DHC Interactions
There are 701 drugs known to interact with Poly-Tussin DHC (brompheniramine / dihydrocodeine / phenylephrine), along with 24 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 147 are major, 550 are moderate, and 4 are minor.
- View all 701 medications that may interact with Poly-Tussin DHC
- View Poly-Tussin DHC alcohol/food interactions (1)
- View Poly-Tussin DHC disease interactions (24)
Most frequently checked interactions
View interaction reports for Poly-Tussin DHC (brompheniramine / dihydrocodeine / phenylephrine) and the medicines listed below.
- Allegra (fexofenadine)
- Aspirin Low Strength (aspirin)
- Crestor (rosuvastatin)
- cyclobenzaprine
- digoxin
- diltiazem
- Dulcolax Laxative (bisacodyl)
- hydrochlorothiazide
- Lidoderm (lidocaine topical)
- Lortab (acetaminophen / hydrocodone)
- meclizine
- MiraLAX (polyethylene glycol 3350)
- multivitamin with minerals
- Naprelan (naproxen)
- Nasonex (mometasone nasal)
- Pradaxa (dabigatran)
- propranolol
- sotalol
- tramadol
- Tylenol Arthritis Pain (acetaminophen)
- Ultram (tramadol)
Poly-Tussin DHC alcohol/food interactions
There is 1 alcohol/food interaction with Poly-Tussin DHC (brompheniramine / dihydrocodeine / phenylephrine).
Poly-Tussin DHC disease interactions
There are 24 disease interactions with Poly-Tussin DHC (brompheniramine / dihydrocodeine / phenylephrine) which include:
- impaired GI motility
- infectious diarrhea
- prematurity
- acute alcohol intoxication
- drug dependence
- hypotension
- intracranial pressure
- respiratory depression
- gastrointestinal obstruction
- cardiovascular disease
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- adrenal insufficiency
- liver disease
- renal dysfunction
- seizure disorders
- urinary retention
- arrhythmias
- biliary tract disease
- BPH
- diabetes
- glaucoma
Report options
More about Poly-Tussin DHC (brompheniramine / dihydrocodeine / phenylephrine)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: upper respiratory combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.